Association of Blood Leukocytes and Hemoglobin with Hospital Mortality in Acute Pulmonary Embolism
Authors:
- Slobodan ObradovicSOSlobodan Obradovic
- Boris DzudovicBDBoris Dzudovic
- Bojana SuboticBSBojana Subotic
- Sonja SalingerSSSonja Salinger
- Jovan MatijasevicJMJovan Matijasevic
- Marija BenicMBMarija Benic
- Tamara KovacevicTKTamara Kovacevic
- Ana Kovacevic-KuzmanovicAKAna Kovacevic-Kuzmanovic
- Irena MitevskaIMIrena Mitevska
- Vladimir MiloradovicVMVladimir Miloradovic
- Ema JevticEJEma Jevtic
- Aleksandar NeskovicANAleksandar Neskovic
Open Access
- 28 September 2023
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (19) , 6269
Abstract
This study aimed to assess the prognostic significance of total leukocyte count (TLC) and hemoglobin (Hb) levels upon admission for patients with acute pulmonary embolism (PE), considering the European Society of Cardiology (ESC) model for mortality risk. 1622 patients from a regional PE registry were included. Decision tree statistics were employed to evaluate the prognostic value of TLC and Hb, both independently and in conjunction with the ESC model. The results indicated all-cause and PE-related in-hospital mortality rates of 10.7% and 6.5%, respectively. Subgrouping patients based on TLC cut-off values (≤11.2, 11.2–16.84, >16.84 × 109/L) revealed increasing all-cause mortality risks (7.0%, 11.8%, 30.2%). Incorporating Hb levels (≤126 g/L or above) further stratified the lowest risk group into two strata with all-cause mortality rates of 10.1% and 4.7%. Similar trends were observed for PE-related mortality. Notably, TLC improved risk assessment for intermediate–high-risk patients within the ESC model, while Hb levels enhanced mortality risk stratification for lower-risk PE patients in the ESC model for all-cause mortality. In conclusion, TLC and Hb levels upon admission can refine the ESC model’s mortality risk classification for patients with acute PE, providing valuable insights for improved patient management.Keywords
All Related Versions
This publication has 30 references indexed in Scilit:
- Leukocytes and systemic inflammatory response syndrome as prognostic factors in pulmonary embolism patientsBMC Pulmonary Medicine, 2013
- White blood cell count and mortality in patients with acute pulmonary embolismAmerican Journal of Hematology, 2013
- Risk stratification and clinical outcomes in patients with acute pulmonary embolismClinical Biochemistry, 2011
- Mean platelet volume predicts early death in acute pulmonary embolismHeart, 2009
- Association of anaemia and mortality in patients with acute pulmonary embolismThrombosis and Haemostasis, 2009
- Role of inflammation in right ventricular damage and repair following experimental pulmonary embolism in ratsInternational Journal of Experimental Pathology, 2008
- Predictive value of white blood cell subtypes for long-term outcome following myocardial infarctionAtherosclerosis, 2008
- Pulmonary embolism causes endomyocarditis in the human heartHeart, 2007
- Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in ratsJournal of Molecular and Cellular Cardiology, 2006
- Catecholamine-Induced Leukocytosis: Early Observations, Current Research, and Future DirectionsBrain, Behavior, and Immunity, 1996